Thank you for contacting us
Please fill out the form below and we will follow up with you the next business day. We ask for your contact information so that we can follow up with you regarding your request. We will not share it with third parties for unsolicited inquiries.

Refer a Patient Please fill out the form below:

Contact Us Please fill out the form below:

Share your storyPlease fill out the form below:

Thank you for sharing

call us
              

 

   Minimize

Clinical Trials

Since proton therapy was approved by the U.S. Food and Drug Administration to treat patients in 1988, the medical community has continued to conduct research on the use of protons in treating different types of cancer through clinical trials. Over the years, many patients have volunteered to take part in these clinical trials to help find improvements in fighting cancer with proton therapy.

As a dedicated provider of proton therapy, ProCure is always looking for ways to improve the lives of patients with cancer. Our team has made a commitment to participate in clinical trials to further our knowledge of the benefits of proton therapy in many tumor types.

What are clinical trials?

Clinical trials are research studies that involve people. They are the final step in a long process that begins with research in a lab. Each study answers a specific set of scientific questions and explores better ways to prevent, screen for, diagnose or treat a disease. Most treatments used today are the results of past clinical trials.

What are protocols?

For every clinical trial, a protocol, or action plan, is prepared prior to conducting the trial. The protocol describes in detail what will be done in the study, how it will be conducted, and why each part of the study is necessary. Each study has its own rules about who can participate. For instance, some studies need patients with a certain condition, some need healthy people, some need just men or just women etc.

Clinical Trials at ProCure Centers

ProCure is currently participating in the clinical trials listed below. Not all trials are available at every center. If you are interested in a particular trial, please refer to the participating center noted at the bottom of the trial description to see if it’s available at the ProCure center near you.


  • NCT01982123: SPECT/CT in Measuring Lung Function in Patients With Lung Cancer Undergoing Radiation Therapy

    This pilot clinical trial studies single photon emission computed tomography (SPECT)/computed tomography (CT) in measuring lung function in patients with lung cancer undergoing radiation therapy. Diagnostic procedures that measure lung function may help doctors find healthy lung tissue and allow them to plan better treatment.

    Participating ProCure center(s): Seattle
    Learn more »

  • REG001-09/NCT01255748: Patients Treated with Proton Therapy
    A registry trial to collect and analyze information from patients treated with proton therapy.

    Participating ProCure center(s): Oklahoma, New Jersey, Seattle
    Learn more »

  • GU002-10/NCT01230866: Low Risk Prostate Cancer (standard fractionation vs. hypo-fractionation)
    A phase III prospective randomized trial comparing the effects (good and bad) on patients with low risk prostate cancer by comparing the standard number of radiation treatments (44 treatments over 8½-9 weeks) with a short course of radiation (5 treatments over 1-2 weeks) using higher radiation dose per treatment to see if the effects of the treatments are similar or better.

    Participating ProCure center(s): Oklahoma
    Learn more »

  • GU003-10/NCT01492972: Intermediate Risk Prostate Cancer
    A phase III trial comparing the effects (good and bad) of hypofraction proton therapy (28 treatments) with or without androgen suppression therapy on patients with intermediate risk prostate cancer.

    Participating ProCure center(s): Oklahoma
    Learn more »

  • UPCC 23309/NCT01126476: Recurrent Tumors
    A study to determine the feasibility of using proton radiotherapy in recurrent malignancies. Patients with histologically confirmed, non-CNS solid malignancies who have been previously radiated and have a tumor recurrence in or near prior radiation fields can participate in the trial.

    Participating ProCure center(s): Oklahoma
    Learn more »

  • BRE007-12/NCT01766297: Early Stage Breast Cancer
    A phase II trial comparing the effects (good and bad) on women with early stage breast cancer using proton radiation therapy.

    Participating ProCure center(s): Oklahoma
    Learn more »

  • BRE008-12/NCT01758445: Stage III Breast Cancer
    A study to look at the rates of acute and long term adverse events of postoperative proton radiotherapy for complex loco-regional irradiation in women with loco-regionally advanced breast cancer. This study specifically includes longitudinal follow up to assess the incidence of cardiac mortality and second malignant neoplasms at 10 and 15 years following proton therapy.

    Participating ProCure center(s): Oklahoma, New Jersey
    Learn more »

  • LUN005-12: A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer
    A research study to compare the effects (good and bad) on subjects and their cancer using standard chemotherapy in combination with hypofractionated proton radiation therapy. Hypofractionation is a technique that delivers higher daily doses of radiation over a shorter
    period of time.

    Participating ProCure center(s): Oklahoma, New Jersey
    Learn more »

Search Clinical Trials

You can search for more clinical trials by visiting http://www.clinicaltrials.gov

Participate in a Trial

If you are interested in participating in a trial listed above, please contact a member of our research team and we will help you with next steps.


Oklahoma
Tisha Adams, Clinical Research Coordinator
Phone: (405) 773-6775
Email address: tisha.adams@okc.procure.com


New Jersey/Metro New York
Carl Brown, Clinical Research Coordinator
Phone: (732) 357-2676
Email address: carl.brown@nj.procure.com